Zimmer Biomet Holdings Inc. (ZBH)
NYSE
Closed
Oct 7, 2026
Day's Range
88.3252 wk Range
79.12Overview - ZBH - Zimmer Biomet Holdings Inc.
Key Statistics
Valuation
Enterprise Value
23.98B
P/E (Trailing)
‪21.42‬
P/E (Forward)
‪9.73‬
PEG Ratio
‪0.63‬
Price / Sales (TTM)
‪1.97‬
Price / Book
‪1.33‬
EV / EBITDA
‪9.49‬
Profitability
Gross Margin
‪70.80%‬
Profit Margin
‪9.48%‬
Operating Margin
‪17.95%‬
Return on Assets
‪3.87%‬
Return on Equity
‪6.41%‬
Ownership
Shares Outstanding
190.56M
Float
190.13M
Short % of Shares Outstanding
‪5.92%‬
Held by Insiders
‪0.15%‬
Held by Institutions
‪111.35%‬
Price stats
Beta
‪0.47‬
50-Day Avg
‪96.11‬
200-Day Avg
‪91.36‬
Dividends
Payout Ratio
‪23.30%‬
Frequency
Quarterly
Analyst Consensus
27 analysts
Average price target
‪$ 107.57‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ZBH - Zimmer Biomet Holdings Inc.
Peers - ZBH - Zimmer Biomet Holdings Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - ZBH - Zimmer Biomet Holdings Inc.
About
Zimmer Biomet Holdings Inc. is a global medical technology company focused on musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip systems, along with sports medicine, biologics, extremities, and trauma solutions. Its portfolio also…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
